Clinical practice guidelines and consensus statements in oncology - An assessment of their methodological quality

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Jacobs, Carmel ^a   Graham, Ian D ^b,c   Makarski, Julie ^d   Chassé, Michaël ^b   Fergusson, Dean ^b,c   Hutton, Brian ^b   Clemons, Mark ^a,c  

^a OTTAWA REGIONAL CANCER CENTRE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^d Independent Consultant   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RESEARCH; CANCER THERAPY; CONSENSUS DEVELOPMENT; DRUG INDUSTRY; HUMAN; PRACTICE GUIDELINE; PROTOCOL COMPLIANCE; PUBLICATION; QUALITY CONTROL; SYSTEMATIC REVIEW; VALIDATION PROCESS; ANALYSIS OF VARIANCE; ONCOLOGY; PATIENT CARE; STANDARDS;

ANALYSIS OF VARIANCE; HUMANS; MEDICAL ONCOLOGY; PATIENT CARE; PRACTICE GUIDELINES AS TOPIC; QUALITY CONTROL;

EID: 84908139093     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0110469     Document Type: Article

References (123)

1. Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J (1999) Potential benefits, limitations, and harms of clinical guidelines. BMJ 318: 527-530.
2. Grimshaw JM, Russell IT (1993) Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet 342: 1317-1322.
3. Graham RMM, Miller Wolman D, Greenfield S, Steinberg E, Editors, Committee on Standards for Developing Trustworthy Clinical Practice Guidelines Clinical Practice Guidelines We Can Trust.: Institute of Medicine. 4. (2009) Mosby's Medical Dictionary. 8th Edition ed: Elsevier.
4. Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, et al. (2010) AGREE II: advancing guideline development, reporting and evaluation in health care. Cmaj 182: E839-842.
5. Guidelines International Network. Available: http://www.g-i-n.net/. Accessed 26 May 2014.
6. Canadian partnership against cancer and pCODR. (2013) How cancer drug funding decisions are made Available: http://www.pcodr.ca/idc/groups/pcodr/documents/pcodrdocument/pcodr-funding-tutorial.pdf. Accessed 28 April 2014.
7. Brouwers (2010) Standards and Guidelines Evidence (SAGE) Directory of Cancer Guidelines. Available: http://www.cancerview.ca/cv/portal/Home/TreatmentAndSupport/TSProfessionals/ClinicalGuidelines/GRCMain/GRCSAGE?-afrLoop=176960541903000&lang=en&-afrWindowMode=0&-adf.ctrl-state=n8sm6f4dx-85. Accessed 28 September 2013.
8. Brouwers MC, Rawski E, Spithoff K, Oliver TK (2011) Inventory of Cancer Guidelines: a tool to advance the guideline enterprise and improve the uptake of evidence. Expert Rev Pharmacoecon Outcomes Res 11: 151-161.
9. Oncology JoC Information for Contributors.
10. Khorana AA, Streiff MB, Farge D, Mandala M, Debourdeau P, et al. (2009) Venous Thromboembolism Prophylaxis and Treatment in Cancer: A Consensus Statement of Major Guidelines Panels and Call to Action. Journal of Clinical Oncology 27: 4919-4926.
11. Laneuville P, Barnett MJ, Belanger R, Couban S, Forrest DL, et al. (2006) Recommendations of the canadian consensus group on the management of chronic myeloid leukemia. Curr Oncol 13: 201-221.
12. Hanna W, O'Malley F P, Barnes P, Berendt R, Gaboury L, et al. (2007) Updated recommendations from the Canadian National Consensus Meeting on HER2/neu testing in breast cancer. Curr Oncol 14: 149-153.
13. Colorectal Cancer Association of Canada consensus meeting: raising the standards of care for early-stage rectal cancer (2009) Curr Oncol 16: 50-56.
14. Ellis PM, Morzycki W, Melosky B, Butts C, Hirsh V, et al. (2009) The role of the epidermal growth factor receptor tyrosine kinase inhibitors as therapy for advanced, metastatic, and recurrent non-small-cell lung cancer: a Canadian national consensus statement. Curr Oncol 16: 27-48.
15. Cripps C, Gill S, Ahmed S, Colwell B, Dowden S, et al. (2010) Consensus recommendations for the use of anti-egfr therapies in metastatic colorectal cancer. Curr Oncol 17: 39-45.
16. Vickers M, Samson B, Colwell B, Cripps C, Jalink D, et al. (2010) Eastern Canadian Colorectal Cancer Consensus Conference: setting the limits of resectable disease. Curr Oncol 17: 70-77.
17. Kocha W, Maroun J, Kennecke H, Law C, Metrakos P, et al. (2010) Consensus recommendations for the diagnosis and management of well-differentiated gastroenterohepatic neuroendocrine tumours: a revised statement from a Canadian National Expert Group. Curr Oncol 17: 49-64.
18. Asmis T, Balaa F, Scully L, Papadatos D, Marginean C, et al. (2010) Diagnosis and management of hepatocellular carcinoma: results of a consensus meeting of The Ottawa Hospital Cancer Centre. Curr Oncol 17: 6-12.
19. Sherman M, Burak K, Maroun J, Metrakos P, Knox JJ, et al. (2011) Multidisciplinary Canadian consensus recommendations for the management and treatment of hepatocellular carcinoma. Curr Oncol 18: 228-240.
20. Aubin F, Gill S, Burkes R, Colwell B, Kamel-Reid S, et al. (2011) Canadian Expert Group consensus recommendations: KRAS testing in colorectal cancer. Curr Oncol 18: e180-184.
21. Vickers MM, Pasieka J, Dixon E, McEwan S, McKay A, et al. (2012) Report from the 13th annual Western canadian gastrointestinal cancer consensus conference; calgary, alberta; september 8-10, 2011. Curr Oncol 19: e468-477.
22. McEwen S, Egan M, Chasen M, Fitch M (2013) Consensus recommendations for cancer rehabilitation: research and education priorities. Curr Oncol 20: 64-69.
23. Pritchard KI, Gelmon KA, Rayson D, Provencher L, Webster M, et al. (2013) Endocrine therapy for postmenopausal women with hormone receptor-positive her2-negative advanced breast cancer after progression or recurrence on nonsteroidal aromatase inhibitor therapy: a Canadian consensus statement. Curr Oncol 20: 48-61.
24. Di Valentin T, Biagi J, Bourque S, Butt R, Champion P, et al. (2013) Eastern Canadian Colorectal Cancer Consensus Conference: standards of care for the treatment of patients with rectal, pancreatic, and gastrointestinal stromal tumours and pancreatic neuroendocrine tumours. Curr Oncol 20: e455-464.
25. Reece D, Imrie K, Stevens A, Smith CA (2006) Bortezomib in multiple myeloma and lymphoma: a systematic review and clinical practice guideline. Curr Oncol 13: 160-172.
26. Maroun J, Kocha W, Kvols L, Bjarnason G, Chen E, et al. (2006) Guidelines for the diagnosis and management of carcinoid tumours. Part 1: the gastrointestinal tract. A statement from a Canadian National Carcinoid Expert Group. Curr Oncol 13: 67-76.
27. Jonker D, Rumble RB, Maroun J (2006) Role of oxaliplatin combined with 5-fluorouracil and folinic acid in the first- and second-line treatment of advanced colorectal cancer. Curr Oncol 13: 173-184.
28. Mason WP, Maestro RD, Eisenstat D, Forsyth P, Fulton D, et al. (2007) Canadian recommendations for the treatment of glioblastoma multiforme. Curr Oncol 14: 110-117.
29. Quirt I, Verma S, Petrella T, Bak K, Charette M, et al. (2007) Temozolomide for the Treatment of Metastatic Melanoma: A Practice Guideline. Current Oncology, {S1}14.
30. Verma S, Younus J, Stys-Norman D, Haynes AE, Blackstein M (2007) Ifosfamide-based combination chemotherapy in advanced soft-tissue sarcoma: a practice guideline. Curr Oncol 14: 144-148.
31. Mintz A, Perry J, Spithoff K, Chambers A, Laperriere N (2007) Management of single brain metastasis: a practice guideline. Curr Oncol 14: 131-143.
32. Fraser G SC, Imrie K, Meyer R (2007) Alemtuzumab in Chronic Lymphocytic Leukemia: A Systematic Review and Clinical Practice Guideline. Current Oncology, {S1}14.
33. Petrella T, Quirt I, Verma S, Haynes AE, Charette M, et al. (2007) Single-Agent Interleukin-2 in the Treatment of Metastatic Melanoma: A Clinical Practice Guideline. Curr Oncol 14: 21-26.
34. Verma S, Petrella T, Hamm C, Bak K, Charette M (2008) Biochemotherapy for the treatment of metastatic malignant melanoma: a clinical practice guideline. Curr Oncol 15: 85-89.
35. Verma S, Younus J, Haynes AE, Stys-Norman D, Blackstein M (2008) Dose-intensive chemotherapy with growth factor or autologous bone marrow or stem-cell transplant support in first-line treatment of advanced or metastatic adult soft tissue sarcoma: a clinical practice guideline. Curr Oncol 15: 80-84.
36. Cripps C, Winquist E, Devries MC, Stys-Norman D, Gilbert R (2010) Epidermal growth factor receptor targeted therapy in stages III and IV head and neck cancer. Curr Oncol 17: 37-48.
37. Elit L, Fyles AW, Oliver TK, Devries-Aboud MC, Fung-Kee-Fung M (2010) Follow-up for women after treatment for cervical cancer. Curr Oncol 17: 65-69.
38. Dawson AJ, McGowan-Jordan J, Chernos J, Xu J, Lavoie J, et al. (2011) Canadian College of Medical Geneticists guidelines for the indications, analysis, and reporting of cancer specimens. Curr Oncol 18: e250-255.
39. Mackenzie M, Spithoff K, Jonker D (2011) Systemic therapy for advanced gastric cancer: a clinical practice guideline. Curr Oncol 18: e202-209.
40. Howell D, Hack TF, Oliver TK, Chulak T, Mayo S, et al. (2011) Survivorship services for adult cancer populations: a pan-Canadian guideline. Curr Oncol 18: e265-281.
41. Darling GE, Dickie AJ, Malthaner RA, Kennedy EB, Tey R (2011) Invasive mediastinal staging of non-small-cell lung cancer: a clinical practice guideline. Curr Oncol 18: e304-310.
42. Dodge JE, Covens AL, Lacchetti C, Elit LM, Le T, et al. (2012) Management of a suspicious adnexal mass: a clinical practice guideline. Curr Oncol 19: e244-257.
43. Chen C, Baldassarre F, Kanjeekal S, Herst J, Hicks L, et al. (2013) Lenalidomide in multiple myeloma-a practice guideline. Curr Oncol 20: e136-149.
44. Gupta AA, Yao X, Verma S, Mackay H, Hopkins L (2013) Chemotherapy (gemcitabine, docetaxel plus gemcitabine, doxorubicin, or trabectedin) in inoperable, locally advanced, recurrent, or metastatic uterine leiomyosarcoma: a clinical practice guideline. Curr Oncol 20: e448-454.
45. Yoo J, Lacchetti C, Hammond JA, Gilbert RW (2013) Role of endolaryngeal surgery (with or without laser) compared with radiotherapy in the management of early (T1) glottic cancer: a clinical practice guideline. Curr Oncol 20: e132-135.
46. Kandel R, Coakley N, Werier J, Engel J, Ghert M, et al. (2013) Surgical margins and handling of soft-tissue sarcoma in extremities: a clinical practice guideline. Curr Oncol 20: e247-254.
47. Gallinger S, Biagi JJ, Fletcher GG, Nhan C, Ruo L, et al. (2013) Liver resection for colorectal cancer metastases. Curr Oncol 20: e255-265.
48. Howell D, Keller-Olaman S, Oliver TK, Hack TF, Broadfield L, et al. (2013) A pan-Canadian practice guideline and algorithm: screening, assessment, and supportive care of adults with cancer-related fatigue. Curr Oncol 20: e233-246.
49. Trautinger F, Knobler R, Willemze R, Peris K, Stadler R, et al. (2006) EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome. European journal of cancer (Oxford, England: 1990) 42: 1014-1030.
50. Van Cutsem E, Nordlinger B, Adam R, Köhne C-H, Pozzo C, et al. (2006) Towards a pan-European consensus on the treatment of patients with colorectal liver metastases. European journal of cancer (Oxford, England: 1990) 42: 2212-2221.
51. Zinzani PL, d'Amore F, Bombardieri E, Brammer C, Codina JG, et al. (2008) Consensus conference: Implementing treatment recommendations on yttrium-90 immunotherapy in clinical practice - Report of a European workshop. European journal of cancer (Oxford, England: 1990) 44: 366-373.
52. Garbe C, Peris K, Hauschild A, Saiag P, Middleton M, et al. (2010) Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline. European journal of cancer (Oxford, England: 1990) 46: 270-283.
53. Amant F, Deckers S, Van Calsteren K, Loibl S, Halaska M, et al. (2010) Breast cancer in pregnancy: Recommendations of an international consensus meeting. European journal of cancer (Oxford, England: 1990) 46: 3158-3168.
54. Gridelli C, Rossi A, Maione P (2011) 2010 Consensus on Lung Cancer, new clinical recommendations and current status of biomarker assessment - Firstline therapy. European journal of cancer (Oxford, England : 1990) 47: S248-S257.
55. Lutz MP, Zalcberg JR, Ducreux M, Ajani JA, Allum W, et al. (2012) Highlights of the EORTC St. Gallen International Expert Consensus on the primary therapy of gastric, gastroesophageal and oesophageal cancer - Differential treatment strategies for subtypes of early gastroesophageal cancer. European journal of cancer (Oxford, England: 1990) 48: 2941-2953.
56. Garbe C, Peris K, Hauschild A, Saiag P, Middleton M, et al. (2012) Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline - Update 2012. European journal of cancer (Oxford, England: 1990) 48: 2375-2390.
57. German Austrian and Swiss consensus conference on the diagnosis and local treatment of the axilla in breast cancer (2103) European journal of cancer (Oxford, England: 1990) 49: 2277-2283.
58. Czauderna P, Otte JB, Aronson DC, Gauthier F, Mackinlay G, et al. (2005) Guidelines for surgical treatment of hepatoblastoma in the modern era- recommendations from the Childhood Liver Tumour Strategy Group of the International Society of Paediatric Oncology (SIOPEL). Eur J Cancer 41: 1031-1036.
59. Becker G, Galandi D, Blum HE (2006) Malignant ascites: systematic review and guideline for treatment. Eur J Cancer 42: 589-597.
60. Aapro MS, Cameron DA, Pettengell R, Bohlius J, Crawford J, et al. (2006) EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours. Eur J Cancer 42: 2433-2453.
61. Bokemeyer C, Aapro MS, Courdi A, Foubert J, Link H, et al. (2007) EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update. Eur J Cancer 43: 258-270.
62. Duffy MJ, van Dalen A, Haglund C, Hansson L, Holinski-Feder E, et al. (2007) Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use. Eur J Cancer 43: 1348-1360.
63. Cataliotti L, De Wolf C, Holland R, Marotti L, Perry N, et al. (2007) Guidelines on the standards for the training of specialised health professionals dealing with breast cancer. Eur J Cancer 43: 660-675.
64. Quinn B, Potting CM, Stone R, Blijlevens NM, Fliedner M, et al. (2008) Guidelines for the assessment of oral mucositis in adult chemotherapy, radiotherapy and haematopoietic stem cell transplant patients. Eur J Cancer 44: 61-72.
65. Maschmeyer G, Beinert T, Buchheidt D, Cornely OA, Einsele H, et al. (2009) Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients: Guidelines of the infectious diseases working party of the German Society of Haematology and Oncology. Eur J Cancer 45: 2462-2472.
66. Glenny AM, Gibson F, Auld E, Coulson S, Clarkson JE, et al. The development of evidence-based guidelines on mouth care for children, teenagers and young adults treated for cancer. European Journal of Cancer 46: 1399-1412.
67. Aapro MS, Bohlius J, Cameron DA, Dal Lago L, Donnelly JP, et al. (2011) 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours. Eur J Cancer 47: 8-32.
68. Rayner L, Price A, Hotopf M, Higginson IJ (2011) The development of evidence-based European guidelines on the management of depression in palliative cancer care. Eur J Cancer 47: 702-712.
69. Herkert JC, Niessen RC, Olderode-Berends MJ, Veenstra-Knol HE, Vos YJ, et al. (2011) Paediatric intestinal cancer and polyposis due to bi-allelic PMS2 mutations: case series, review and follow-up guidelines. Eur J Cancer 47: 965-982.
70. (2012) EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. Eur J Cancer 48: 599-641.
71. Juweid ME, Stroobants S, Hoekstra OS, Mottaghy FM, Dietlein M, et al. (2007) Use of Positron Emission Tomography for Response Assessment of Lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. Journal of Clinical Oncology 25: 571-578.
72. Ponzoni M, Ferreri AJM, Campo E, Facchetti F, Mazzucchelli L, et al. (2007) Definition, Diagnosis, and Management of Intravascular Large B-Cell Lymphoma: Proposals and Perspectives From an International Consensus Meeting. Journal of Clinical Oncology 25: 3168-3173.
73. Philip PA, Mooney M, Jaffe D, Eckhardt G, Moore M, et al. (2009) Consensus Report of the National Cancer Institute Clinical Trials Planning Meeting on Pancreas Cancer Treatment. Journal of Clinical Oncology 27: 5660-5669.
74. Tsukasaki K, Hermine O, Bazarbachi A, Ratner L, Ramos JC, et al. (2009) Definition, Prognostic Factors, Treatment, and Response Criteria of Adult T-Cell Leukemia-Lymphoma: A Proposal From an International Consensus Meeting. Journal of Clinical Oncology 27: 453-459.
75. Lokhorst H, Einsele H, Vesole D, Bruno B, Miguel JS, et al. (2010) International Myeloma Working Group Consensus Statement Regarding the Current Status of Allogeneic Stem-Cell Transplantation for Multiple Myeloma. Journal of Clinical Oncology 28: 4521-4530.
76. Dimopoulos MA, Terpos E, Chanan-Khan A, Leung N, Ludwig H, et al. (2010) Renal Impairment in Patients With Multiple Myeloma: A Consensus Statement on Behalf of the International Myeloma Working Group. Journal of Clinical Oncology 28: 4976-4984.
77. Thomas MB, Jaffe D, Choti MM, Belghiti J, Curley S, et al. (2010) Hepatocellular Carcinoma: Consensus Recommendations of the National Cancer Institute Clinical Trials Planning Meeting. Journal of Clinical Oncology 28: 3994-4005.
78. Kulke MH, Siu LL, Tepper JE, Fisher G, Jaffe D, et al. (2011) Future Directions in the Treatment of Neuroendocrine Tumors: Consensus Report of the National Cancer Institute Neuroendocrine Tumor Clinical Trials Planning Meeting. Journal of Clinical Oncology 29: 934-943.
79. Olsen EA, Whittaker S, Kim YH, Duvic M, Prince HM, et al. (2011) Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer. Journal of Clinical Oncology 29: 2598-2607.
80. Brock PR, Knight KR, Freyer DR, Campbell KCM, Steyger PS, et al. (2012) Platinum-Induced Ototoxicity in Children: A Consensus Review on Mechanisms, Predisposition, and Protection, Including a New International Society of Pediatric Oncology Boston Ototoxicity Scale. Journal of Clinical Oncology 30: 2408-2417.
81. Lyman GH, Giuliano AE, Somerfield MR, Benson AB, 3rd, Bodurka DC, et al. (2005) American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23: 7703-7720.
82. Desch CE, Benson AB, Somerfield MR, Flynn PJ, Krause C, et al. (2005) Colorectal Cancer Surveillance: 2005 Update of an American Society of Clinical Oncology Practice Guideline. Journal of Clinical Oncology 23: 8512-8519.
83. Wolff AC, Hammond MEH, Schwartz JN, Hagerty KL, Allred DC, et al. (2006) American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer. Journal of Clinical Oncology 25: 118-145.
84. Smith TJ, Khatcheressian J, Lyman GH, Ozer H, Armitage JO, et al. (2006) 2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice Guideline. Journal of Clinical Oncology 24: 3187-3205.
85. Pfister DG, Laurie SA, Weinstein GS, Mendenhall WM, Adelstein DJ, et al. (2006) American Society of Clinical Oncology Clinical Practice Guideline for the Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer. Journal of Clinical Oncology 24: 3693-3704.
86. Kris MG, Hesketh PJ, Somerfield MR, Feyer P, Clark-Snow R, et al. (2006) American Society of Clinical Oncology Guideline for Antiemetics in Oncology: Update 2006. Journal of Clinical Oncology 24: 2932-2947.
87. Lyman GH, Khorana AA, Falanga A, Clarke-Pearson D, Flowers C, et al. (2007) American Society of Clinical Oncology Guideline: Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer. Journal of Clinical Oncology 25: 5490-5505.
88. Pisters KMW, Evans WK, Azzoli CG, Kris MG, Smith CA, et al. (2007) Cancer Care Ontario and American Society of Clinical Oncology Adjuvant Chemotherapy and Adjuvant Radiation Therapy for Stages I-IIIA Resectable Non-Small-Cell Lung Cancer Guideline. Journal of Clinical Oncology 25: 5506-5518.
89. Basch EM, Somerfield MR, Beer TM, Carducci MA, Higano CS, et al. (2007) American Society of Clinical Oncology Endorsement of the Cancer Care Ontario Practice Guideline on Nonhormonal Therapy for Men With Metastatic Hormone-Refractory (castration-resistant) Prostate Cancer. Journal of Clinical Oncology 25: 5313-5318.
90. Kyle RA, Yee GC, Somerfield MR, Flynn PJ, Halabi S, et al. (2007) American Society of Clinical Oncology 2007 Clinical Practice Guideline Update on the Role of Bisphosphonates in Multiple Myeloma. Journal of Clinical Oncology 25: 2464-2472.
91. Loblaw DA, Virgo KS, Nam R, Somerfield MR, Ben-Josef E, et al. (2007) Initial Hormonal Management of Androgen-Sensitive Metastatic, Recurrent, or Progressive Prostate Cancer: 2007 Update of an American Society of Clinical Oncology Practice Guideline. Journal of Clinical Oncology 25: 1596-1605.
92. Hensley ML, Hagerty KL, Kewalramani T, Green DM, Meropol NJ, et al. (2009) American Society of Clinical Oncology 2008 Clinical Practice Guideline Update: Use of Chemotherapy and Radiation Therapy Protectants. Journal of Clinical Oncology 27: 127-145.
93. Kramer BS, Hagerty KL, Justman S, Somerfield MR, Albertsen PC, et al. (2009) Use of 5-alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline. J Clin Oncol 27: 1502-1516.
94. Azzoli CG, Baker S, Temin S, Pao W, Aliff T, et al. (2009) American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer. Journal of Clinical Oncology 27: 6251-6266.
95. Visvanathan K, Chlebowski RT, Hurley P, Col NF, Ropka M, et al. (2009) American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Pharmacologic Interventions Including Tamoxifen, Raloxifene, and Aromatase Inhibition for Breast Cancer Risk Reduction. Journal of Clinical Oncology 27: 3235-3258.
96. Rizzo JD, Brouwers M, Hurley P, Seidenfeld J, Arcasoy MO, et al. (2010) American Society of Clinical Oncology/American Society of Hematology Clinical Practice Guideline Update on the Use of Epoetin and Darbepoetin in Adult Patients With Cancer. Journal of Clinical Oncology 28: 4996-5010.
97. Burstein HJ, Prestrud AA, Seidenfeld J, Anderson H, Buchholz TA, et al. (2010) American Society of Clinical Oncology Clinical Practice Guideline: Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer. Journal of Clinical Oncology 28: 3784-3796.
98. Gilligan TD, Seidenfeld J, Basch EM, Einhorn LH, Fancher T, et al. (2010) American Society of Clinical Oncology Clinical Practice Guideline on Uses of Serum Tumor Markers in Adult Males With Germ Cell Tumors. Journal of Clinical Oncology 28: 3388-3404.
99. Hammond MEH, Hayes DF, Dowsett M, Allred DC, Hagerty KL, et al. (2010) American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer. Journal of Clinical Oncology 28: 2784-2795.
100. Basch E, Prestrud AA, Hesketh PJ, Kris MG, Feyer PC, et al. (2011) Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update. Journal of Clinical Oncology 29: 4189-4198.
101. Griggs JJ, Somerfield MR, Anderson H, Henry NL, Hudis CA, et al. (2011) American Society of Clinical Oncology Endorsement of the Cancer Care Ontario Practice Guideline on Adjuvant Ovarian Ablation in the Treatment of Premenopausal Women With Early-Stage Invasive Breast Cancer. Journal of Clinical Oncology 29: 3939-3942.
102. Azzoli CG, Temin S, Aliff T, Baker S, Brahmer J, et al. (2011) 2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer. Journal of Clinical Oncology 29: 3825-3831.
103. Burstein HJ, Mangu PB, Somerfield MR, Schrag D, Samson D, et al. (2011) American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Chemotherapy Sensitivity and Resistance Assays. Journal of Clinical Oncology 29: 3328-3330.
104. Wong SL, Balch CM, Hurley P, Agarwala SS, Akhurst TJ, et al. (2012) Sentinel Lymph Node Biopsy for Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Joint Clinical Practice Guideline. Journal of Clinical Oncology 30: 2912-2918.
105. Griggs JJ, Mangu PB, Anderson H, Balaban EP, Dignam JJ, et al. (2012) Appropriate Chemotherapy Dosing for Obese Adult Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline. Journal of Clinical Oncology 30: 1553-1561.
106. Visvanathan K, Hurley P, Bantug E, Brown P, Col NF, et al. (2013) Use of Pharmacologic Interventions for Breast Cancer Risk Reduction: American Society of Clinical Oncology Clinical Practice Guideline. Journal of Clinical Oncology 31: 2942-2962.
107. Loren AW, Mangu PB, Beck LN, Brennan L, Magdalinski AJ, et al. (2013) Fertility Preservation for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. Journal of Clinical Oncology 31: 2500-2510.
108. Schiffer CA, Mangu PB, Wade JC, Camp-Sorrell D, Cope DG, et al. (2013) Central venous catheter care for the patient with cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 31: 1357-1370.
109. Khatcheressian JL, Hurley P, Bantug E, Esserman LJ, Grunfeld E, et al. (2013) Breast Cancer Follow-Up and Management After Primary Treatment: American Society of Clinical Oncology Clinical Practice Guideline Update. Journal of Clinical Oncology 31: 961-965.
110. Flowers CR, Seidenfeld J, Bow EJ, Karten C, Gleason C, et al. (2013) Antimicrobial Prophylaxis and Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology Clinical Practice Guideline. Journal of Clinical Oncology 31: 794-810.
111. Fervers B, Burgers JS, Haugh MC, Brouwers M, Browman G, et al. (2005) Predictors of high quality clinical practice guidelines: examples in oncology. Int J Qual Health Care 17: 123-132.
112. Burgers JS, Fervers B, Haugh M, Brouwers M, Browman G, et al. (2004) International assessment of the quality of clinical practice guidelines in oncology using the Appraisal of Guidelines and Research and Evaluation Instrument. J Clin Oncol 22: 2000-2007.
113. de Haas ER, de Vijlder HC, van Reesema WS, van Everdingen JJ, Neumann HA (2007) Quality of clinical practice guidelines in dermatological oncology. J Eur Acad Dermatol Venereol 21: 1193-1198.
114. Shimbo T, Fukui T, Ishioka C, Okamoto K, Okamoto T, et al. (2010) Quality of guideline development assessed by the Evaluation Committee of the Japan Society of Clinical Oncology. Int J Clin Oncol 15: 227-233.
115. Langton JM, Drew AK, Mellish L, Olivier J, Ward RL, et al. (2011) The quality of web-based oncology guidelines and protocols: how do international sites stack up? Br J Cancer 105: 1166-1172.
116. Hogeveen SE, Han D, Trudeau-Tavara S, Buck J, Brezden-Masley CB, et al. (2012) Comparison of international breast cancer guidelines: are we globally consistent? cancer guideline AGREEment. Curr Oncol 19: e184-190.
117. Lopez-Olivo MA, Kallen MA, Ortiz Z, Skidmore B, Suarez-Almazor ME (2008) Quality appraisal of clinical practice guidelines and consensus statements on the use of biologic agents in rheumatoid arthritis: a systematic review. Arthritis Rheum 59: 1625-1638.
118. Collaboration TC (2014) Understanding Searching Techniques to Inform HTA, Systematic Reviews and Guideline Development.
119. Graham R, Mancher M, Wolman DM, Greenfield S, Steinberg E (2011) Clinical Practice Guidelines We Can Trust. The National Academies Press.
120. Mendelson TB, Meltzer M, Campbell EG, Caplan AL, Kirkpatrick JN (2011) COnflicts of interest in cardiovascular clinical practice guidelines. Archives of Internal Medicine 171: 577-584.
121. American Society of Clinical Oncology (2013) Conflict of Interest Policy Implementation for Clinical Practice Guidelines of American Society of Clinical Oncology. http://www.asco.org/sites/www.asco.org/files/conflict-of-interest-policy-implementation-for-clinical-practice-guidelines-8.8.2013-0.pdf [Accessed 28 May 2014].
122. Norris SL, Holmer HK, Ogden LA, Burda BU (2011) Conflict of interest in clinical practice guideline development: a systematic review. PLoS One 6: e25153.
123. Cosgrove L, Bursztajn HJ, Erlich DR, Wheeler EE, Shaughnessy AF (2013) Conflicts of interest and the quality of recommendations in clinical guidelines. Journal of Evaluation in Clinical Practice 19: 674-681.